A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer

Julian Molina, Daniel Nikcevich, Shauna Hillman, Susan Geyer, Timothy Drevyanko, James Jett, Joseph Verdirame, Henry Tazelaar, Kendrith Rowland, Edward Wos, Leila Kutteh, Suresh Nair, Tom Fitch, Patrick Flynn, Philip Stella, Alex Adjei

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences